Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Complement activation and inflammation].

Masayoshi Abe1

  • 1Department of Pharmacology, Faculty of Medicine, Fukuoka University, Fukuoka.

Rinsho Byori. the Japanese Journal of Clinical Pathology
|August 18, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

G Protein-Coupled Glutamate and GABA Receptors Form Complexes and Mutually Modulate Their Signals.

ACS chemical neuroscience·2020
Same author

Lack of modulatory effect of the SCN5A R1193Q polymorphism on cardiac fast Na+ current at body temperature.

PloS one·2018
Same author

Monitoring of glutamate-induced excitotoxicity by mitochondrial oxygen consumption.

Synapse (New York, N.Y.)·2018
Same author

A mutant HCN4 channel in a family with bradycardia, left bundle branch block, and left ventricular noncompaction.

Heart and vessels·2018
Same author

Effect of dibutyltin on placental and fetal toxicity in rat.

The Journal of toxicological sciences·2017
Same author

Histopathology of a wavy medaka.

Journal of toxicologic pathology·2016

The complement system, crucial for defense, can over-amplify inflammation. Regulators control its activation, but targeting anaphylatoxins (C3a, C5a) offers anti-inflammatory drug development opportunities.

Area of Science:

  • Immunology
  • Pharmacology
  • Molecular Biology

Background:

  • The complement system is vital for innate immunity but can cause excessive inflammation when dysregulated.
  • Regulators of complement activation (RCA) control this system, preventing harmful overactivity.
  • Complement activation produces anaphylatoxins (C3a, C5a) and the membrane attack complex (MAC).

Purpose of the Study:

  • To explore the role of complement activation in inflammatory diseases.
  • To identify therapeutic targets for modulating complement system activity.
  • To review strategies for pharmacological intervention in complement-mediated disorders.

Main Methods:

  • Review of complement system pathways and regulatory mechanisms.
  • Analysis of anaphylatoxins (C3a, C5a) and their receptors.

Related Experiment Videos

  • Examination of current and emerging therapeutic strategies for complement inhibition.

    • Main Results:

    • Complement activation contributes to various inflammatory and autoimmune diseases.
    • Anaphylatoxins C3a and C5a, acting via specific receptors, are key mediators of inflammation.
    • Several therapeutic approaches, including receptor antagonists and inhibitors, are under development.

    Conclusions:

    • Targeting the complement system, particularly anaphylatoxin receptors, holds promise for treating inflammatory and immune-related conditions.
    • Pharmacological manipulation of complement activation presents a viable strategy for novel drug discovery.
    • Ongoing clinical trials are evaluating the efficacy of complement-targeted therapies for diseases like ARDS and rheumatoid arthritis.